SWHR Statement in Appreciation for Commissioner Hamburg’s Service
Washington, DC, February 5, 2015 – The Society for Women’s Health Research (SWHR) would like to commend the outgoing Food and Drug Administration (FDA) Commissioner, Dr. Margaret Hamburg, for her profound service to improve American public health at the Agency.
In a statement issued today, SWHR President and CEO, Phyllis Greenberger, expressed “I have worked with a number of FDA Commissioners over the years and none have so successfully changed the direction of the FDA in such a positive way and been so responsive to collaboration with stakeholders.”
During her time as Commissioner, Hamburg successfully led the charge of increasing transparency, oversight and responsibility in the industries of food, drugs, tobacco, cosmetics and medical devices. Under her leadership, FDA has significantly grown accelerated approval processes for new drugs. Hamburg’s FDA has focused on using advanced regulatory science and placing emphasis on public-private partnerships. This strategy has enabled the agency to better meet the needs of its stakeholders.
Greenberger continued, “As the CEO of the Society for Women’s Health Research, I am particularly pleased about the policy changes that have occurred under Commissioner Hamburg’s leadership; namely ensuring the inclusion of women and minorities in clinical trials and the emphasis on the importance of sub group analysis and clinical relevancy for all populations. This is something we have been advocating for years and it is exciting to see it finally come to fruition. We applaud the significant achievements that have taken place under her leadership. She leaves an impressive legacy and a role that will be difficult to fill.”
About SWHR
The Society for Women’s Health Research (SWHR) is the national thought leader in the study of biological differences in disease, dedicated to transforming women’s health through science, advocacy and education. SWHR advocates for increased public and private funding for women’s health; greater inclusion of women and minorities in medical studies; and analysis of the biological differences between men and women in disease and health issues. For more information, visit www.SWHR.org.
###
Media Contact:
202-496-5008
Washington, DC, February 5, 2015 – The Society for Women’s Health Research (SWHR) would like to commend the outgoing Food and Drug Administration (FDA) Commissioner, Dr. Margaret Hamburg, for her profound service to improve American public health at the Agency.
In a statement issued today, SWHR President and CEO, Phyllis Greenberger, expressed “I have worked with a number of FDA Commissioners over the years and none have so successfully changed the direction of the FDA in such a positive way and been so responsive to collaboration with stakeholders.”
During her time as Commissioner, Hamburg successfully led the charge of increasing transparency, oversight and responsibility in the industries of food, drugs, tobacco, cosmetics and medical devices. Under her leadership, FDA has significantly grown accelerated approval processes for new drugs. Hamburg’s FDA has focused on using advanced regulatory science and placing emphasis on public-private partnerships. This strategy has enabled the agency to better meet the needs of its stakeholders.
Greenberger continued, “As the CEO of the Society for Women’s Health Research, I am particularly pleased about the policy changes that have occurred under Commissioner Hamburg’s leadership; namely ensuring the inclusion of women and minorities in clinical trials and the emphasis on the importance of sub group analysis and clinical relevancy for all populations. This is something we have been advocating for years and it is exciting to see it finally come to fruition. We applaud the significant achievements that have taken place under her leadership. She leaves an impressive legacy and a role that will be difficult to fill.”
About SWHR
The Society for Women’s Health Research (SWHR) is the national thought leader in the study of biological differences in disease, dedicated to transforming women’s health through science, advocacy and education. SWHR advocates for increased public and private funding for women’s health; greater inclusion of women and minorities in medical studies; and analysis of the biological differences between men and women in disease and health issues. For more information, visit www.SWHR.org.
###
Media Contact:
202-496-5008